EWJ vs IBB
iShares MSCI Japan ETF vs iShares Biotechnology ETF
- • IBB has the lower expense ratio at 0.44% vs 0.49% for EWJ.
- • EWJ pays a higher dividend yield (3.83%).
Side-by-side metrics
| Metric | EWJ | IBB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.49% | 0.44% |
Dividend yield Trailing 12-month yield. | 3.83% | 0.16% |
AUM Assets under management — bigger funds are typically more liquid. | $23.40B | $11.50B |
YTD return | 13.91% | 30.22% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.86 | 0.60 |
P/E ratio | 14.99 | 25.48 |
Last price | $92.01 | $217.75 |
Inception | — | — |
Issuer | iShares | iShares |
EWJ top holdings
| 8306.T | Mitsubishi UFJ Financial Group Inc | 4.52% |
| 7203.T | Toyota Motor Corp | 3.58% |
| 6857.T | Advantest Corp | 3.14% |
| 6098.T | Recruit Holdings Co Ltd | 3.13% |
| 8316.T | Sumitomo Mitsui Financial Group Inc | 2.89% |
| 6758.T | Sony Group Corp | 2.83% |
| 6501.T | Hitachi Ltd | 2.77% |
| 8035.T | Tokyo Electron Ltd | 2.60% |
| 8411.T | Mizuho Financial Group Inc | 2.21% |
| 9984.T | SoftBank Group Corp | 2.04% |
IBB top holdings
| GILD | Gilead Sciences Inc | 8.94% |
| AMGN | Amgen Inc | 8.31% |
| VRTX | Vertex Pharmaceuticals Inc | 7.87% |
| REGN | Regeneron Pharmaceuticals Inc | 6.24% |
| MRNA | Moderna Inc | 5.49% |
| NTRA | Natera Inc | 3.78% |
| ARGX | argenx SE ADR | 3.36% |
| BIIB | Biogen Inc | 2.52% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.50% |
| ILMN | Illumina Inc | 2.41% |
About EWJ
EWJ (iShares MSCI Japan ETF) is Japanese large- and mid-cap equities. Managed by iShares, the fund carries $23.4B in assets under management, an expense ratio of 0.49%, a dividend yield of 3.83%. Its largest holding is Mitsubishi UFJ Financial Group Inc (8306.T), which represents 4.5% of the portfolio. Real Estate is the fund's largest sector exposure at 1.9%.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $11.5B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.16%. Its largest holding is Gilead Sciences Inc (GILD), which represents 8.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.